YK11 is a partial agonist of androgen receptor , with osteogenic activity. In Vitro YK11 is a partial agonist of androgen receptor, and induces myogenic differentiation of C2C12 Cells at 500 nM via Fst mRNA upregulation by AR. YK11 enhances Myf5 and myogenin mRNA expression, but requires high concentrations (YK11, 100?nM or 500?nM). YK11 (0.5?μM) increases the cell growth of osteoblastic MC3T3-E1 cells, and enhances ALP activity via AR. YK11 also elevates osteoprotegerin mRNA expression (0.5?μM) and dose-dependently increases osteocalcin mRNA expression (0.1-1.0 μM). In addition, YK11 enhances phosphorylation of Akt protein via rapid non-genomic signaling. MCE has not independently confirmed the accuracy of these methods. They are for reference only. Form:Solid IC50& Target:Androgen receptor
All
Chemical Reagents
Biomedicine
Organic raw materials
Inorganic chemical industry
intermediate
Agricultural chemicals
Auxiliaries and catalysts
Fragrances and Flavors
Dyes and Pigments
Daily chemical industry
YK11
CAS number：1370003-76-1 molecular formula：C25H34O6
overview
compound introduction
Specs
| Chinese alias | - | ||
| English alias | YK11 | YK-11 | DTXSID301107018 | 19-Norpregna-4,20-diene-21-carboxylic acid, 17,20-((1-methoxyethylidene)bis(oxy))-3-oxo-, methyl ester, (17alpha,20E)- | Q27295178 | Z9748J6B0R | 1370003-76-1 | UNII-Z9748J6B0R | YK11 cpd | (17alpha,20E)-17,20-((1-Methoxye | ||
| CAS number | 1370003-76-1 | molecular formula | C25H34O6 |
| molecular weight | 430.53 g/mol | Exact mass | ≥98% |
| PSA | - | logp | - |
numbering system
No numbering system information yet
physicochemical properties
No physical and chemical property information yet
Safety information
No safety information yet
Production methods and uses
No production method and use information yet
Related
upstream information
No upstream information yet
downstream information
No downstream information yet
MSDS
Found 0 shareMSDS
